Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9137 - 9144 of 11456 results
The Court's Decision in the FLANAX US Trademark Dispute Gives Bayer a Headache
February 25, 2015| Blog| Viewpoint
Bayer Given a Headache by Trial Court Decision in FLANAX US Trademark Dispute
February 25, 2015| Blog| Viewpoint
The YouTube Kids app is here! Now what?
February 25, 2015| Blog| Viewpoint
ML Strategies: Keystone XL, Energy Efficiency Heat Up in Congress
February 25, 2015| Blog| Viewpoint
Telehealth Bill Moving Forward in Florida-But Medicaid Coverage Sacrificed
February 25, 2015| Blog| Viewpoint
FTC-DOJ Workshop on Health Care Competition Enters Second Day
February 25, 2015| Blog| Viewpoint
Workplace Challenges in 2015, Part 3 of 5: Beware of Stop-Loss Coverage Gaps When Choosing a Self-Funded Major Medical Plan
February 24, 2015| Blog| Viewpoint
ACA Countdown to Compliance For Employers - Complete Volume Available
February 24, 2015| Blog| Viewpoint
News & Press Releases
Mintz is pleased to announce that 31 attorneys have been named Massachusetts Super Lawyers and 35 attorneys have been named Massachusetts Rising Stars for 2024.
Mintz IP Group Named “Litigation Department of the Year” in 2024 New England Legal Awards
October 02, 2024
Mintz’s intellectual property litigation group was named “Litigation Department of the Year” for the IP specialty category in the 2024 New England Legal Awards. The awards recognize attorneys and firms in Connecticut, Maine, Vermont, New Hampshire, Massachusetts, and Rhode Island.
Defending AI, Machine Learning Patents In Life Sciences
October 1, 2024
Intellectual Property Chair Michael Renaud and Associates Meena Seralathan, Simone Yhap, and Williams Dixon recently wrote an article for Law360 focused on protecting artificial intelligence and machine learning patents in the life sciences industry following the US Supreme Court’s 2014 decision in Alice v. CLS Bank.